107 related articles for article (PubMed ID: 21069298)
21. Probing the interactions among sphingosine and phytosphingosine ceramides with non- and alpha-hydroxylated acyl chains in skin lipid model membranes.
Čuříková-Kindlová BA; Diat O; Štěpánek F; Vávrová K; Zbytovská J
Int J Pharm; 2019 May; 563():384-394. PubMed ID: 30959237
[TBL] [Abstract][Full Text] [Related]
22. The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients.
van Smeden J; Janssens M; Kaye EC; Caspers PJ; Lavrijsen AP; Vreeken RJ; Bouwstra JA
Exp Dermatol; 2014 Jan; 23(1):45-52. PubMed ID: 24299153
[TBL] [Abstract][Full Text] [Related]
23. Probing the role of the ceramide acyl chain length and sphingosine unsaturation in model skin barrier lipid mixtures by (2)H solid-state NMR spectroscopy.
Stahlberg S; Školová B; Madhu PK; Vogel A; Vávrová K; Huster D
Langmuir; 2015 May; 31(17):4906-15. PubMed ID: 25870928
[TBL] [Abstract][Full Text] [Related]
24. Different phase behavior and packing of ceramides with long (C16) and very long (C24) acyls in model membranes: infrared spectroscopy using deuterated lipids.
Školová B; Hudská K; Pullmannová P; Kováčik A; Palát K; Roh J; Fleddermann J; Estrela-Lopis I; Vávrová K
J Phys Chem B; 2014 Sep; 118(35):10460-70. PubMed ID: 25122563
[TBL] [Abstract][Full Text] [Related]
25. Barrier Capability of Skin Lipid Models: Effect of Ceramides and Free Fatty Acid Composition.
Uche LE; Gooris GS; Bouwstra JA; Beddoes CM
Langmuir; 2019 Nov; 35(47):15376-15388. PubMed ID: 31698908
[TBL] [Abstract][Full Text] [Related]
26. Permeability and lipid organization of a novel psoriasis stratum corneum substitute.
Basse LH; Groen D; Bouwstra JA
Int J Pharm; 2013 Nov; 457(1):275-82. PubMed ID: 24036087
[TBL] [Abstract][Full Text] [Related]
27. Model membranes prepared with ceramide EOS, cholesterol and free fatty acids form a unique lamellar phase.
Groen D; Gooris GS; Bouwstra JA
Langmuir; 2010 Mar; 26(6):4168-75. PubMed ID: 20121267
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of membrane raft formation: fatty acid domains in stratum corneum lipid models.
Moore DJ; Snyder RG; Rerek ME; Mendelsohn R
J Phys Chem B; 2006 Feb; 110(5):2378-86. PubMed ID: 16471828
[TBL] [Abstract][Full Text] [Related]
29. Increased Levels of Short-Chain Ceramides Modify the Lipid Organization and Reduce the Lipid Barrier of Skin Model Membranes.
Uche LE; Gooris GS; Bouwstra JA; Beddoes CM
Langmuir; 2021 Aug; 37(31):9478-9489. PubMed ID: 34319754
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the molecular structure of the human stratum corneum ceramides [NP] and [EOS] by mass spectrometry.
Hinder A; Schmelzer CE; Rawlings AV; Neubert RH
Skin Pharmacol Physiol; 2011; 24(3):127-35. PubMed ID: 21212722
[TBL] [Abstract][Full Text] [Related]
31. The phase behaviour of skin lipid mixtures based on synthetic ceramides.
de Jager MW; Gooris GS; Dolbnya IP; Bras W; Ponec M; Bouwstra JA
Chem Phys Lipids; 2003 Jul; 124(2):123-34. PubMed ID: 12818738
[TBL] [Abstract][Full Text] [Related]
32. Fourier transform infrared spectroscopy studies of lipid domain formation in normal and ceramide deficient stratum corneum lipid models.
Gorcea M; Hadgraft J; Moore DJ; Lane ME
Int J Pharm; 2012 Oct; 435(1):63-8. PubMed ID: 22107708
[TBL] [Abstract][Full Text] [Related]
33. Profiling of human stratum corneum ceramides by means of normal phase LC/APCI-MS.
Farwanah H; Wohlrab J; Neubert RH; Raith K
Anal Bioanal Chem; 2005 Oct; 383(4):632-7. PubMed ID: 16184366
[TBL] [Abstract][Full Text] [Related]
34. The role of the trans double bond in skin barrier sphingolipids: permeability and infrared spectroscopic study of model ceramide and dihydroceramide membranes.
Skolová B; Jandovská K; Pullmannová P; Tesař O; Roh J; Hrabálek A; Vávrová K
Langmuir; 2014 May; 30(19):5527-35. PubMed ID: 24779554
[TBL] [Abstract][Full Text] [Related]
35. Human stratum corneum lipid organization as observed by atomic force microscopy on Langmuir-Blodgett films.
Norlén L; Gil IP; Simonsen A; Descouts P
J Struct Biol; 2007 Jun; 158(3):386-400. PubMed ID: 17287132
[TBL] [Abstract][Full Text] [Related]
36. Properties of ceramides and their impact on the stratum corneum structure. Part 2: stratum corneum lipid model systems.
Kessner D; Ruettinger A; Kiselev MA; Wartewig S; Neubert RH
Skin Pharmacol Physiol; 2008; 21(2):58-74. PubMed ID: 18187965
[TBL] [Abstract][Full Text] [Related]
37. Molecular Dynamics Simulation of Skin Lipids: Effect of Ceramide Chain Lengths on Bilayer Properties.
Gupta R; Dwadasi BS; Rai B
J Phys Chem B; 2016 Dec; 120(49):12536-12546. PubMed ID: 27973837
[TBL] [Abstract][Full Text] [Related]
38. Phase behaviour of skin barrier model membranes at pH 7.4.
Bouwsta JA; Gooris GS; Dubbelaar FE; Ponec M
Cell Mol Biol (Noisy-le-grand); 2000 Jul; 46(5):979-92. PubMed ID: 10976878
[TBL] [Abstract][Full Text] [Related]
39. Very Long Chain Lipids Favor the Formation of a Homogeneous Phase in Stratum Corneum Model Membranes.
Ramos AP; Bouwstra JA; Lafleur M
Langmuir; 2020 Nov; 36(46):13899-13907. PubMed ID: 33170015
[TBL] [Abstract][Full Text] [Related]
40. Characterization of overall ceramide species in human stratum corneum.
Masukawa Y; Narita H; Shimizu E; Kondo N; Sugai Y; Oba T; Homma R; Ishikawa J; Takagi Y; Kitahara T; Takema Y; Kita K
J Lipid Res; 2008 Jul; 49(7):1466-76. PubMed ID: 18359959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
